Hengsheng Medical has raised nearly 300 million yuan ($46 million) in its Series A round from CMB International and CITIC Medial & Health, while Hamedal has garnered 100 million yuan ($15 million) in its Series A round led by GGV Capital.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
